Xi'an-Janssen Ibrutinib Capsules 140 mg Package Insert

Ibrutinib capsules are a medication used to treat mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma. The recommended dose of ibrutinib capsules is once daily, at approximately the same time each day. Swallow the capsules whole with water. Do not open, break or chew the capsules.


Xi'an-Janssen Ibrutinib Capsules 140 mg Package Insert - cover page
Brand
Xi'an-Janssen
Category
Drugs
Document type
Other
Language
Chinese
Pages
31
File format
PDF
File size
1 MB
Published
15 November, 2023
Updated
15 November, 2023
MD5 checksum
1B71EB7D1A2A376F66E30C0421EE91A0

About this manual

This is the Chinese package insert for Ibrutinib Capsules (商品名称 亿珂®/IMBRUVICA®), a 140 mg hard gelatin capsule from Xi'an-Janssen. It states that the capsules, taken orally once daily, are indicated as monotherapy for patients with mantle cell lymphoma (MCL) and for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) who have received at least one prior therapy.

The insert details the recommended doses (560 mg once daily for MCL; 420 mg once daily for CLL/SLL), dose adjustments for toxicity, co-administration with CYP3A inhibitors, use in hepatic impairment, missed doses, and special populations such as women and men of childbearing potential. It then presents adverse reaction data from clinical trials including PCYC-1104-CA, MCL-3001, PCYC-1102-CA, PCYC-1112-CA, PCYC-1115-CA and CLL-3001. This manual is written in Chinese.

What's inside

  • Drug Name
  • Ingredients
  • Description
  • Indications
  • Specification
  • Dosage and Administration
  • Dose Adjustment
  • Missed Dose
  • Special Populations
  • Adverse Reactions

Specifications

Active ingredientIbrutinib (伊布替尼)
Strength140 mg
Molecular formulaC25H24N6O2
Molecular weight440.50
Capsule appearanceSize 0 white opaque hard gelatin capsule printed in black ink with "ibr 140mg"; contents are white or almost white powder
ExcipientsMicrocrystalline cellulose, croscarmellose sodium, sodium lauryl sulfate, magnesium stearate, gelatin empty capsule
Recommended dose for MCL560 mg (4 capsules of 140 mg) once daily until disease progression or unacceptable toxicity
Recommended dose for CLL/SLL420 mg (3 capsules of 140 mg) once daily until disease progression or unacceptable toxicity

Frequently asked questions

What is Ibrutinib Capsules indicated for?

It is used as monotherapy for patients with mantle cell lymphoma who have received at least one prior therapy, and for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma who have received at least one prior therapy.

How should Ibrutinib Capsules be taken?

The capsules are given orally once daily, swallowed whole with water at roughly the same time each day; do not open, break or chew the capsule.

What should I do if I miss a dose?

If a dose is not taken at the planned time, it can be taken as soon as possible the same day, and the normal schedule resumes the next day; do not take an extra dose to make up for the missed one.

What is the recommended dose for mantle cell lymphoma?

The recommended dose for MCL is 560 mg (four 140 mg capsules) once daily until disease progression or unacceptable toxicity.

Download PDF (1 MB)